Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Corrigendum to ‘Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis’
Corrigendum to ‘Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis’
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Journal of the European Academy of Dermatology and Venereology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Evolution of dupilumab‐associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO‐ADOC study)
by: Ziad Reguiai, et al.
Published: (2024)
Addressing potential bias when assessing safety of biologics and JAK inhibitors in atopic dermatitis
by: Lian F. van der Gang, et al.
Published: (2026)
Psychological impact on flare patterns and severity of atopic dermatitis
by: Mia‐Louise Nielsen, et al.
Published: (2024)
Correspondence to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis’
by: Shiuan‐Chih Chen, et al.
Published: (2025)
Interpreting the risk of venous thromboembolism with JAK inhibitors in atopic dermatitis
by: Sheng Li, et al.
Published: (2025)
